MedTrace Logo

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

NCT01931059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-04-30

Study results available
· View outcomes & findings →

Summary

To detect the effect of second-generation antipsychotic drug on the neural activity.

Conditions

  • Imaging of the Brain and Antipsychotics
  • Neuronal Network Changes

Interventions

DRUG

Risperidone

We gave oral liquid of risperidone one time 1-2 mg depending on subject's weight.

OTHER

Placebo

We gave oral liquid without active risperidone (pt and provider were both double blinded)

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Miklos Argyelan, MD · Northwell Health

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01931059 on ClinicalTrials.gov